Clarivate Analytics introduces Cortellis Content-as-a-Service (CaaS) to accelerate drug discovery and development
(17 Jul 2019) Clarivate Analytics plc (NYSE:CCC; CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today launched an expansion to its Cortellis suite of life science intelligence solutions with programmatic access to scientific data typically used in drug discovery and early stage development. The initial launch includes continually-updated systems biology…